{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:21:57Z","timestamp":1788448917026,"version":"build-2803163510"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00234","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T11:11:02Z","timestamp":1589886662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["A Novel MAX Gene Mutation Variant in a Patient With Multiple and \u201cComposite\u201d Neuroendocrine\u2013Neuroblastic Tumors"],"prefix":"10.3389","volume":"11","author":[{"given":"Carlotta","family":"Pozza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Di Dato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Sbardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Schiavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antongiulio","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giannetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"B1","volume-title":"WHO Classification of Tumours of Endocrine Organs.","author":"Lloyd","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The international neuroblastoma pathology classification (the shimada system)","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrclinonc.2014.168","article-title":"Mechanisms of neuroblastoma regression","volume":"11","author":"Brodeur","year":"2014","journal-title":"Nat Rev Clinical Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"37730","DOI":"10.18632\/oncotarget.17146","article-title":"Clinical and biological features of neuroblastic tumors: a comparison of neuroblastoma and ganglioneuroblastoma","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","article-title":"Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours","volume":"28","author":"Lam","year":"2017","journal-title":"Endocr Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4158\/EP09205.RA","article-title":"Composite pheochromocytoma-ganglioneuroma: a rare experiment of nature","volume":"16","author":"Khan","year":"2010","journal-title":"Endocr. Prac."},{"key":"B7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1309\/AJCPN76VTIGWPOAG","article-title":"Composite pheochromocytoma: a clinicopathologic and molecular comparison with ordinary pheochromocytoma and neuroblastoma","volume":"132","author":"Comstock","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-19-0021","article-title":"Management of endocrine disease: precision medicine in neuroendocrine neoplasms: an update on current management and future perspectives","volume":"181","author":"Gaudenzi","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metabol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cancers11101505","article-title":"Current management of pheochromocytoma\/paraganglioma: a guide for the practicing clinician in the era of precision medicine","volume":"11","author":"Nolting","year":"2019","journal-title":"Cancers"},{"key":"B11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12020-017-1310-9","article-title":"Routine genetic screening with a multi-gene panel in patients with pheochromocytomas","volume":"59","author":"Sbardella","year":"2018","journal-title":"Endocrine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12885-017-3486-z","article-title":"Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma","volume":"17","author":"Dwight","year":"2017","journal-title":"BMC Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12885-016-2802-3","article-title":"Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model","volume":"16","author":"Bader","year":"2016","journal-title":"BMC Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"T201","DOI":"10.1530\/ERC-18-0085","article-title":"65 YEARS OF THE DOUBLE HELIX: genetics informs precision practice in the diagnosis and management of pheochromocytoma","volume":"25","author":"Neumann","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fendo.2018.00515","article-title":"Update of pheochromocytoma syndromes: genetics, biochemical evaluation, and imaging","volume":"9","author":"Alrezk","year":"2018","journal-title":"Front Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000457957","article-title":"ENETS consensus guidelines for the standard of care in neuroendocrine tumors","volume":"105","author":"Pavel","year":"2017","journal-title":"Neuroendocrinology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000471879","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging","volume":"105","author":"Sundin","year":"2017","journal-title":"Neuroendocrinology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.6004\/jnccn.2015.0011","article-title":"Neuroendocrine tumors, version 1","volume":"13","author":"Kulke","year":"2015","journal-title":". JNCCN"},{"key":"B19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.6004\/jnccn.2018.0056","article-title":"NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018","volume":"16","author":"Shah","year":"2018","journal-title":"JNCCN"},{"key":"B20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fendo.2019.00333","article-title":"Pheochromocytomas and paragangliomas as causes of endocrine hypertension","volume":"10","author":"Canu","year":"2019","journal-title":"Front Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000499497","article-title":"Peptide receptor radionuclide therapy as a novel treatment for metastatic and invasive phaeochromocytoma and paraganglioma","volume":"109","author":"Mak","year":"2019","journal-title":"Neuroendocrinology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s12020-017-1515-y","article-title":"Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytoma","volume":"59","author":"Gravel","year":"2018","journal-title":"Endocrine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/cancers11020195","article-title":"Efficacy and safety of ablative therapy in the treatment of patients with metastatic pheochromocytoma and paraganglioma","volume":"11","author":"Kohlenberg","year":"2019","journal-title":"Cancers"},{"key":"B24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1055\/a-0715-1888","article-title":"Metastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options","volume":"127","author":"Nolting","year":"2019","journal-title":"Exp Clin Endocrinol Diabet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fendo.2020.00061","article-title":"Temozolomide is a potential therapeutic tool for patients with metastatic pheochromocytoma\/paraganglioma-case report and review of the literature","volume":"11","author":"Tong","year":"2020","journal-title":"Front Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2019.00053","article-title":"Clinical, diagnostic, and treatment characteristics of SDHA-Related metastatic pheochromocytoma and paraganglioma","volume":"9","author":"Jha","year":"2019","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1530\/EJE-10-0758","article-title":"A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma","volume":"164","author":"Burnichon","year":"2011","journal-title":"Eur J Edocrinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","article-title":"Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention","volume":"3","author":"Bausch","year":"2017","journal-title":"JAMA Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1070","DOI":"10.3390\/cancers11081070","article-title":"Pheochromocytomas and paragangliomas: new developments with regard to classification, genetics, and cell of origin","volume":"11","author":"Koopman","year":"2019","journal-title":"Cancers"},{"key":"B30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcdb.2015.05.011","article-title":"Models of parent-of-origin tumorigenesis in hereditary paraganglioma","volume":"43","author":"Hoekstra","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13256-017-1364-6","article-title":"Bilateral pheochromocytoma with ganglioneuroma component associated with multiple neuroendocrine neoplasia type 2A: a case report","volume":"11","author":"Efared","year":"2017","journal-title":"J Med Case Rep"},{"key":"B32","first-page":"15369","article-title":"Diverse proportion in composite pheochromocytoma-ganglioneuroma may induce varied clinical symptom: comparison of two cases","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13104-015-1233-6","article-title":"Composite pheochromocytoma of the adrenal gland: a case series","volume":"8","author":"Shida","year":"2015","journal-title":"BMC Res Notes."},{"key":"B34","doi-asserted-by":"publisher","first-page":"864","DOI":"10.4158\/EP14010.OR","article-title":"Clinical and radiologic features of pheochromocytoma\/ganglioneuroma composite tumors: a case series with comparative analysis","volume":"20","author":"Shawa","year":"2014","journal-title":"Endocr Pract"},{"key":"B35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/0974-7796.110011","article-title":"Composite pheochromocytoma-ganglioneuroma of the adrenal gland: a case report with immunohistochemical study","volume":"5","author":"Rao","year":"2013","journal-title":"Urology Ann"},{"key":"B36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1746-1596-8-63","article-title":"Retroperitoneal composite pheochromocytoma-ganglioneuroma : a case report and review of literature","volume":"8","author":"Hu","year":"2013","journal-title":"Diagnostic Pathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pan.2012.02.001","article-title":"Functional 'composite' pheochromocytoma-ganglioneuroma presenting as a pancreatic mass","volume":"12","author":"Majumder","year":"2012","journal-title":"Pancreatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.anndiagpath.2010.02.005","article-title":"Mixed cortical adenoma and composite pheochromocytoma-ganglioneuroma: an unusual corticomedullary tumor of the adrenal gland","volume":"15","author":"Lau","year":"2011","journal-title":"Ann Diagnostic Pathol"},{"key":"B39","first-page":"1594","article-title":"Extra-adrenal composite pheochromocytoma-ganglioneuroma","volume":"27","author":"Tohme","year":"2006","journal-title":"Saudi Med J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/BF03345345","article-title":"Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene","volume":"28","author":"Bernini","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"B41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/BF02739777","article-title":"Composite pheochromocytoma-ganglioneuroma of the adrenal gland: an uncommon entity with distinctive clinicopathologic features","volume":"10","author":"Lam","year":"1999","journal-title":"Endocr Pathol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/00000478-199701000-00011","article-title":"Composite pheochromocytoma\/ganglioneuroma of the adrenal gland associated with multiple endocrine neoplasia 2A: case report with immunohistochemical analysis","volume":"21","author":"Brady","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/00000478-199308000-00009","article-title":"Bilateral pheochromocytoma-ganglioneuroma of the adrenal in type 1 neurofibromatosis","volume":"17","author":"Chetty","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"B44","first-page":"470","article-title":"Pheochromocytoma-ganglioneuroma of the adrenal","volume":"109","author":"Kragel","year":"1985","journal-title":"Arch Pathol Lab Med"},{"key":"B45","first-page":"144","article-title":"Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors","volume":"41","author":"Mendelsohn","year":"1979","journal-title":"Lab Invest J Tech Methods Pathol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/mpo.2950240609","article-title":"Neuroblastoma IV-S followed by extra-adrenal pheochromocytoma 15 years later","volume":"24","author":"Lopez-Andreu","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-Mendez","year":"2011","journal-title":"Nat Genet"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00109-015-1306-y","article-title":"Functional and in silico assessment of MAX variants of unknown significance","volume":"93","author":"Comino-Mendez","year":"2015","journal-title":"J Mol Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/cen.12218","article-title":"Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma\/paraganglioma patients with clinical characteristics of hereditary syndromes","volume":"79","author":"Peczkowska","year":"2013","journal-title":"Clin Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ccr.2005.06.015","article-title":"Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer","volume":"8","author":"Lee","year":"2005","journal-title":"Cancer Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/ijc.28868","article-title":"Opposing effects of HIF1alpha and HIF2alpha on chromaffin cell phenotypic features and tumor cell proliferation: insights from myc-associated factor x","volume":"135","author":"Qin","year":"2014","journal-title":"Int J Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1530\/EJE-11-1098","article-title":"A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine","volume":"166","author":"Nozieres","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s40792-017-0408-x","article-title":"Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report","volume":"3","author":"Shibata","year":"2017","journal-title":"Surg Case Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1210\/js.2017-00135","article-title":"Case Report of a Prolactinoma in a Patient With a Novel MAX Mutation and Bilateral Pheochromocytomas","volume":"1","author":"Roszko","year":"2017","journal-title":"J Endocr Soc"},{"key":"B56","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12022-016-9460-5","article-title":"Pathological and genetic characterization of bilateral adrenomedullary hyperplasia in a patient with germline max mutation","volume":"28","author":"Romanet","year":"2017","journal-title":"Endocr Pathol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2015-2592","article-title":"Complex max rearrangement in a family with malignant pheochromocytoma, renal oncocytoma, and erythrocytosis","volume":"101","author":"Korpershoek","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1102\/1470-7330.2007.0007","article-title":"Renal and adrenal tumours in children","volume":"7","author":"McHugh","year":"2007","journal-title":"Cancer Imag."},{"key":"B59","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1210\/er.2002-0013","article-title":"Pheochromocytoma: state-of-the-art and future prospects","volume":"24","author":"Bravo","year":"2003","journal-title":"Endocr Rev"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00234\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T11:11:06Z","timestamp":1589886666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00234\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":59,"alternative-id":["10.3389\/fendo.2020.00234"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00234","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"article-number":"234"}}